Home | Welcome to Contract Pharma   
Last Updated Friday, August 22 2014
Print

Breaking News

August 21, 2014
Karaboutis to drive technology initiatives  Read More »
August 21, 2014
To produce prostate cancer drug at its commercial facility in St. Louis  Read More »
August 20, 2014
Will initiate a Phase I trial of ES414 within the next six months  Read More »
August 20, 2014
Expands geographic scale, manufacturing and lyophilization capabilities  Read More »
August 20, 2014
Will evaluate combination regimen of nivolumab and ABRAXANE  Read More »
August 19, 2014
Girão replaces Saad  Read More »
August 19, 2014
To develop novel formulations to enhance bioavailability  Read More »
August 19, 2014
Evotec to provide compound management services to support malaria research  Read More »
August 18, 2014
Hindman succeeds Edwards  Read More »
August 18, 2014
To manufacture API for branded commercial drug  Read More »
August 15, 2014
Will invest £54 million and add 348 new jobs  Read More »
August 15, 2014
Adds next-gen sequencing to testing portfolio  Read More »
August 15, 2014
Herendeen to oversee ERP implementation to complete full separation from Pfizer  Read More »
August 15, 2014
Advances ISIS-SMN Rx in Spinal Muscular Atrophy  Read More »
August 15, 2014
Vassilopoulo and Chaturvedi to head QA and QC  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On